Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Active, Not Recruiting

A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type

NCT04414163

Conditions
Extranodal NK/T-cell Lymphoma, Extranodal NK/T-cell Lymphoma, Nasal Type, Lymphoma, +5 more
Locations
  • Chonnam National University Hwasun Hospital Gwangju, South Korea
  • Asan Medical Center Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
  • Seoul National University Hospital Seoul, South Korea
View Trial Details
Active, Not Recruiting

EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy

NCT04921787

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Boston University Boston, Massachusetts, United States
  • Hennepin Healthcare Research Institute Minneapolis, Minnesota, United States
  • New York University New York, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Active, Not Recruiting

AG-120 in People With IDH1 Mutant Chondrosarcoma

NCT04278781

Conditions
Chondrosarcoma, Chondrosarcoma, Grade 2, Chondrosarcoma, Grade 3, +14 more
Locations
  • Johns Hopkins Hospital (Data Collection Only) Baltimore, Maryland, United States
  • Columbia University (Specimen Analysis Only) New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • The Ohio State University (Data Collection Only) Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies

NCT03932331

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Changchun, China
View all 23 locations
View Trial Details
Active, Not Recruiting

A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma

NCT05888493

Conditions
Disease Attributes, Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, +12 more
Locations
  • Novartis Investigative Site Camperdown, New South Wales, Australia
  • Novartis Investigative Site Clayton, Victoria, Australia
  • Novartis Investigative Site Melbourne, Victoria, Australia
  • Novartis Investigative Site Nedlands, Western Australia, Australia
View all 30 locations
View Trial Details

Related conditions